Trial intelligence / Profile preview

Dexmedetomidine dose effects on intraoperative neurophysiological monitoring during spinal neurosurgery

ChiCTR2000031001Phase 4Not yet recruiting

Sponsor
Beijing Friendship Hospital
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dexmedetomidine (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Somatosensory evoked potential amplitude, Somatosensory evoked potential latency and 2 more. Planned start Apr 2020; status: not yet recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on ChiCTR2000031001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000031001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call